Q2 2024 EPS Estimates for REGENXBIO Inc. (NASDAQ:RGNX) Cut by Leerink Partnrs

REGENXBIO Inc. (NASDAQ:RGNX – Free Report) – Stock analysts at Leerink Partnrs dropped their Q2 2024 earnings per share estimates for REGENXBIO in a research note issued on Wednesday, May 8th. Leerink Partnrs analyst M. Foroohar now expects that the biotechnology company will post earnings of ($1.19) per share for the quarter, down from their […]

Related Keywords

Canada ,United States ,China ,Steve Pakola ,Leerink Partnrs ,Stifel Nicolaus ,Allspring Global Investments Holdings ,Headlands Technologies ,China Universal Asset Management Co ,Financial Services Group Inc ,Barclays ,Regenxbio Inc ,Technology Platform ,Royal Bank ,Annandale Capital ,Nasdaq ,Free Report ,Get Free Report ,Services Group ,Global Investments Holdings ,China Universal Asset Management ,Universal Asset Management ,